Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlæge Camilla Holm ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   2.0% 2.0% 1.8% 1.5% 1.0% 1.0% 6.8% 6.8%   Credit score (0-100)   70 70 72 75 85 85 35 35   Credit rating   A A A A A A BBB BBB   Credit limit (kDKK)   0.1 0.1 0.5 4.5 65.6 113.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,833 1,873 1,961 2,081 2,135 2,810 0.0 0.0   EBITDA   536 523 541 680 741 1,098 0.0 0.0   EBIT   359 334 280 434 500 861 0.0 0.0   Pre-tax profit (PTP)   189.7 179.6 138.9 330.8 411.3 793.0 0.0 0.0   Net earnings   147.4 140.1 108.2 258.0 320.4 626.3 0.0 0.0   Pre-tax profit without non-rec. items   190 180 139 331 411 793 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   610 535 766 602 443 287 0.0 0.0   Shareholders equity total   231 263 261 406 612 788 238 238   Interest-bearing liabilities   199 76.2 413 117 0.0 0.0 735 735   Balance sheet total (assets)   2,289 2,246 2,424 2,050 1,886 1,891 973 973   Net Debt   164 -95.1 237 46.5 -171 -410 735 735     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,833 1,873 1,961 2,081 2,135 2,810 0.0 0.0   Gross profit growth   20.0% 2.2% 4.7% 6.1% 2.6% 31.6% -100.0% 0.0%   Employees   3 3 3 3 3 3 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,289 2,246 2,424 2,050 1,886 1,891 973 973   Balance sheet change%   4.9% -1.9% 7.9% -15.4% -8.0% 0.3% -48.5% 0.0%   Added value   536.0 522.5 541.5 679.9 746.7 1,098.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -133 -345 -111 -493 -481 -474 -287 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   19.6% 17.9% 14.3% 20.8% 23.4% 30.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   16.1% 14.8% 12.1% 19.4% 25.5% 45.7% 0.0% 0.0%   ROI %   92.4% 66.4% 42.6% 54.1% 61.6% 91.7% 0.0% 0.0%   ROE %   70.1% 56.7% 41.3% 77.4% 63.0% 89.5% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   10.1% 11.5% 10.8% 19.8% 32.4% 41.7% 24.5% 24.5%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   30.7% -18.2% 43.9% 6.8% -23.0% -37.3% 0.0% 0.0%   Gearing %   86.2% 29.0% 158.2% 28.9% 0.0% 0.0% 308.6% 308.6%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   171.6% 113.5% 58.7% 38.9% 154.5% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.1 0.2 0.2 0.2 0.3 0.6 0.0 0.0   Current Ratio   0.1 0.2 0.2 0.2 0.3 0.7 0.0 0.0   Cash and cash equivalent   34.8 171.3 175.2 71.0 170.8 410.0 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,698.3 -1,469.8 -1,516.1 -1,135.6 -666.7 -287.7 -367.6 -367.6   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   179 174 180 227 249 366 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   179 174 180 227 247 366 0 0   EBIT / employee   120 111 93 145 167 287 0 0   Net earnings / employee   49 47 36 86 107 209 0 0